5 mg: BLL801A: Dec-19: 33342-051-10: Macleods Pharmaceuticals Limited: Losartan Potassium and Hydrochlorothiazide Tablets 100 mg/ 12
was recalling 19 Lots of Losartan Potassium tablets to the consumer level due to presence of NMBA exceeding
It belongs to the family of angiotensin II receptor antagonists (ARB), which includes Valsartan and Irbesartan
Your doctor may adjust your dose as needed
makers of Losartan Potassium tablets, is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level
This is a repackaged label
This is part of an ongoi n g issue with angiotensin II receptor blocker (ARB) medications
was recalling 19 Lots of Losartan Potassium tablets to the consumer level due to presence of NMBA exceeding the FDAs
The latest recall number for this product is D-0895-2023 and the recall is Camber, Avet, Teva, and Torrent were affected by the recall
Pill with imprint LU P23 is White, Capsule/Oblong and has been identified as Losartan Potassium 100 mg
The recall involves losartan and potassium/hydrochlorothiazide combination pills found to contain N-Nitroso-N-methyl-4-aminobutyric acid, or NMBA, according to a notice posted by the U
Losartan (Cozaar) is a common medication used to treat high blood pressure (hypertension)
Pill with imprint E 47 is Green, Oval and has been identified as Losartan Potassium 100 mg
Losartan potassium tablets USP, 50 mg are white, round, biconvex, film-coated tablets debossed with "12" on scoreline side and plain on other side